The UMass Medical School campus and a 5.25-acre lot on Brooks Street owned by Tore Services Inc. are two potential locations for a new 40,000-square-feet clinic for the U.S. Department of Veterans Affairs.
The American Society for Biochemistry and Molecular Biology has called for C. Robert Matthews, PhD, chair and professor of biochemistry & molecular pharmacology, and Cynthia N Fuhrmann, PhD, assistant professor of biochemistry & molecular pharmacology, to lead a committee that will define the function and activities of a new center established by the society to promote career development among graduates and postdocs.
Steven C. Hatch, MD, assistant professor of medicine, discusses his new book, Snowball in a Blizzard: A Physician’s Notes on Uncertainty in Medicine.
Catherine Wang from Lexington High School was the winner of the 10th annual Central Massachusetts Regional Brain Bee. The event was organized by the UMMS psychiatry department and moderated by Sheldon Benjamin, MD, professor of psychiatry.
Warren J. Ferguson, MD, professor of family medicine & community health, was honored by his peers of the Worcester District Medical Society as the district’s 2016 Community Clinician of the Year, an award recognizing his professionalism and contributions as a physician.
Jonathan Kay, MD, professor of medicine, talks about the FDA advisory committee’s approval of CT-P13, a biosimilar infliximab developed by Celltrion in South Korea, used to treat inflammatory disease.
Edward Ginns, MD, PhD, professor of psychiatry, has identified genetic pathways that exacerbate severity of canine compulsive disorder in Doberman pinschers, a discovery that could lead to better therapies for obsessive compulsive disorder in people.
Lilly, one of two mobile libraries in Worcester, is being renovated. Part of Worcester’s One City, One Library project, Lilly was funded in part by UMass Medical School.
News that Tufts Associated Health Plans had reached an agreement with the state of Massachusetts regarding the requirement to provide comprehensive coverage for Applied Behavior Analysis therapy session for members on the autism spectrum references resources available at the Eunice Kennedy Shriver Center.
The Serum Institute of India (SII) and MassBiologics have developed a fast-acting monoclonal antibody (RMAb) for rabies that they plan to release this year.
Terence R. Flotte, MD, the Celia and Isaac Haidak Professor of Medical Education, executive deputy chancellor, provost and dean of the School of Medicine, comments on new research which found that therapeutic gene transfer to specific brain regions tied to Alzheimer's have uncovered multiple potential treatment approaches that have promise for clinical gene therapy applications.
A story about a new drug court being added to Hingham District Court notes that UMass Medical School will provide training to a new prosecutor to help offenders set up services they need to treat their addiction.
UMass Medical School led the five-campus University of Massachusetts system with $250.3 million in sponsored research.
An op-ed advocating for telemedicine references a UMass Medical School study which found that patients with access to telehealth services were 26 percent more likely to survive the ICU and were discharged from the unit 20 percent faster than those without telehealth access.
A partnership between UMass Medical School, Baystate Medical Center and UMass Amherst is expected to begin operating in Springfield in the fall of 2017 and will bring increased clinical trial access to people in Western Massachusetts.
An article about plans by the Massachusetts Life Sciences Center continuing to invest in Central Massachusetts references the agency’s support of UMass Medical School.
Paul L. Jeffrey, PharmD, pharmacy director at Commonwealth Medicine, has been named chairman of the Eastern Medicaid Pharmacy Administrators Association.
The five-campus University of Massachusetts system has added several first class facilities over the last several years, including the Sherman Center at UMass Medical School.
Sherry Pagoto, PhD, associate professor of medicine, explains how social media can be used to promote healthy lifestyles.
Led by David Paydarfar, MD, professor and vice chair of neurology, a team of scientists and clinicians at UMass Medical School, the Wyss Institute for Biologically Inspired Engineering and the Beth Israel Deaconess Medical Center, have shown in a clinical trial that a new vibration-based prevention technology reduces apneic events in prematurely born infants.
An article about the effects of drinking on health references a study by Gyongyi Szabo, MD, PhD, professor of medicine, which found that a single episode of excessive drinking can have significant negative health effects resulting in bacteria leaking from the gut, leading to increased levels of toxins in the blood.
Sodexo, which provides food to UMass Medical School and UMass Memorial Medical Center, has expressed interest in purchasing locally grown food from a recently formed regional food hub.
A study by Robert J. Goldberg, PhD, professor of quantitative health sciences, shows that the incidence of cardiogenic shock among acute MI patients has stayed steady while mortality from it has declined over the past decade.
Gang Han, PhD, assistant professor of biochemistry & molecular pharmacology, has developed a new optogenetic technology that can trigger the immune system to attack cancer cells.
Jeffrey J. Rade, MD, professor of medicine, discusses a clinical trial that attempts to use adult cardiac stem cells to repair scar tissue left by a heart attack.
Cynthia A. Ennis, DO, assistant professor of medicine, explains that more women die of cardiovascular disease, including strokes, than all forms of cancer combined.
Benjamin U. Nwosu, MD, associate professor of pediatrics, takes part in a discussion about a new study of U.S. teens which found that metabolic syndrome has become less severe since 1999, though no less prevalent, largely because of improved lipid profiles linked to healthier diets.
Lawrence J. Hayward, MD, PhD, professor of neurology, comments on new research which found that mutated FUS proteins gain toxic function in mice with ALS.
Mark Alkema, PhD, associate professor of neurobiology, is part of a team of researchers that developed a state-of-the-art microscope that can peer into the brains of animals in real time. Dr. Alkema and others will use this new technology to observe the flood of sensory information — everything an animal touches, tastes, smells, sees and hears — into the brain and see how that translates into behavior.
According to a 2012 study conducted by UMass Medical School, the length of stay for limited-English-proficiency patients was significantly longer when professional interpreters were not used at admission or both admission and discharge.
Mary Maloney, MD, professor of medicine, comments on the FDA Arthritis Advisory Committee’s recent vote in favor of a biosimilar of Johnson & Johnson’s rheumatoid arthritis treatment Remicade, which, if the FDA approves it, would be the second biosimilar approved in the U.S. and the first of a monoclonal antibody.
Rita Bortell, PhD, research professor of molecular medicine, and Agata Jurczyk, PhD, instructor in molecular medicine, have discovered that a shared gene (or genes) may underlie the co-occurrence of schizophrenia and diabetes.
Gov. Charlie Baker met with UMass Medical School officials to discuss how to incorporate lessons about addiction into the medical school curriculum.
A new study shows that in cells undergoing senescence, chromosomes tend to become more compact. In the article Jeanne B. Lawrence, PhD, interim chair and professor of cell & developmental biology, explains how the structure of chromatin and the chromosomes they form change as cells age.
Terence R. Flotte, MD, the Celia and Isaac Haidak Professor of Medical Education, executive deputy chancellor, provost and dean of the School of Medicine, spoke to the Association of American Medical Colleges in Washington, D.C. about changes to the School of Medicine curriculum, which includes an immersive training module, geared to training medical students about prescribing opioids and preventing abuse.
Wen Xue, PhD, assistant professor of molecular medicine, has found a way to more efficiently deliver a CRISPR/Cas9 therapeutic to adult mice with the metabolic disease Tyrosinemia type I that may also prove to be safer for use in humans. His research shows that administering the treatment by combining two delivery mechanisms already in clinical development for other diseases led to correction of the mutated gene that causes the rare liver disorder in 6 percent of liver cells -- enough to effectively cure the disease in mice.
Wen Xue, PhD, assistant professor of molecular medicine, has found a way to more efficiently deliver a CRISPR/Cas9 therapeutic to adult mice with the metabolic disease Tyrosinemia type I that may also prove to be safer for use in humans.
Sherry Pagoto, PhD, associate professor of medicine, comments on her research that suggests excessive tanning could be a flag for other mental health issues in some patients.
Mark Klempner, MD, executive vice chancellor for MassBiologics and professor of medicine, took local politicians on a tour of the MassBiologics South Coast facility, which just received a good manufacturing process designation by federal regulators. Chancellor Michael F. Collins was also quoted in the article.
Raphael A Carandang, MD, assistant professor of neurology, calls a new stent retriever treatment for stroke patients “the second revolutionary therapeutic breakthrough in acute stroke care in the last 50 years.”